• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Epidemiology of Influenza B infection in the State of Rio Grande do Sul, Brazil, from 2003 to 2019

tetano

Editor, Senior Moderator
J Med Virol


. 2021 Jan 26.
doi: 10.1002/jmv.26822. Online ahead of print.
Epidemiology of Influenza B infection in the State of Rio Grande do Sul, Brazil, from 2003 to 2019


Marina Beretta Duarte[SUP] 1 [/SUP], Tatiana Sch?ffer Gregianini[SUP] 2 [/SUP], Let?cia G Martins[SUP] 3 [/SUP], Ana Beatriz G Veiga[SUP] 1 [/SUP]



Affiliations

Abstract

Introduction: Influenza B virus (IBV) causes respiratory tract infections with mild, moderate or life-threatening symptoms. This study describes the epidemiology of IBV infection in Rio Grande do Sul (RS), Brazil, along 17 years.
Method: Nasopharyngeal samples were collected from outpatients presenting acute respiratory illness (ARI) between 2003 and 2019, and from inpatients with severe acute respiratory infection (SARI) from 2009 to 2019. IBV was detected by immunofluorescence assay or RT-qPCR; demographic and clinical data were analyzed.
Results: In total, 48,656 cases of respiratory infection were analyzed, of which 20.45% were ARI, and 79.46% were SARI. Respiratory viruses accounted for 22.59% and 37.47% of the cases of ARI and SARI, respectively. Considering respiratory viral infections, 17.10% of ARI and 3.06% of SARI were associated to IBV. IBV circulated year-round in RS, with an increase in autumn and winter, peaking in July (p=0.005). IBV infection showed association with age, and most outpatients positive for IBV were between 10-49 years old, whereas IBV infection in SARI affected mainly individuals ≤1 year or ≥60 years old. No significant association was found between sex and IBV infection. Coryza, sore throat and myalgia were associated with ARI (p<0.001). Moreover, 3.18% of the deaths associated with respiratory virus infection were positive for IBV; notably, cardiopathy (p<0.001), metabolic disease (p<0.001), and smoking (p=0.003) were associated to fatality in IBV infection.
Conclusions: IBV is an important cause of severe respiratory infections, and fatality risk is high in individuals with cardiopathy and metabolic diseases. This article is protected by copyright. All rights reserved.

Keywords: IBV infection; acute respiratory illness; influenza B virus; respiratory virus; severe acute respiratory infection; surveillance..
 
Back
Top Bottom